News & Comment

From stories making mainstream headlines in the UK, to regulatory developments across the globe, catch up on the latest news in the medical

Dr Callie Seaman, a leading UK plant scientist and co-chair of the Cannabis Industry Council, joins Hannah Deacon and Professor Mike Barnes

Biden Administration confirms rescheduling of cannabis in US   History was made on 16 May, as President Biden confirmed he was accepting t

This month, Hannah and Mike speak to Pierre van Weperen, CEO of Grow Pharma, a joint venture between GROW Group and IPS Pharma in the UK.

This month Maple Tree headed to Europe’s largest and longest-running cannabis B2B event, the International Cannabis Business Conference

We are proud to announce the launch of the first publication in our new evidence base series, An Introduction to Medical Cannabis. Designed

From stories making mainstream headlines in the UK, to regulatory developments across Europe, catch up on the latest news in the medical...

The cannabis industry is increasingly under fire from cybercriminals, with recent breaches making it clear that no company is immune....

From stories making mainstream headlines in the UK, to regulatory developments across Europe, catch up on the latest news in the medical...

The Maple Tree podcast is back with another episode, in which we ask Melissa Sturgess, CEO of Ananda Developments, ‘What’s Your Why’? In...

Maple Tree is attending ICBC Berlin in April for Europe’s largest and longest running cannabis B2B event this spring.

The Maple Tree Consultant’s podcast What’s Your Why returned this week with the second episode featuring Katya Kowalski of Volteface.

Maple Tree's What’s Your Why podcast looks beyond commercial forecasts to make space for open and honest conversations.

Are you a new business hoping to break into the UK medical cannabis industry? Here’s everything you need to know.

Five years ago, the UK stood at the edge of a revolutionary change in its medical and economic landscape: the legalisation of medical...